Statins for primary cardiovascular prevention in the elderly.

[43] , [44] The first included more than 70,000 subjects found some benefits, particularly for all- cause mortality and major coronary and cerebrovascular events, in subjects over 65 years; however, they did not reach statistical significance.

also in 111,027 other papers